Gastroenterology

GLP1-RA drugs for diabetes may heighten risk of gastric retention during upper endoscopy. Research suggests continued use may not warrant procedure cancellations.

This News Feature explores the current use of anti-TNF combination therapy with immunomodulators for Crohn’s disease and ulcerative colitis in adults and children.

Patients who underwent surgery for inflammatory bowel disease (IBD) reported better physical health 1 month after surgery, according to research. Read more.

Anti-TNF therapy can lead to significant improvement in growth disturbances among children with Crohn’s disease: the number of patients with growth disturbances notably decreased 12 and 24 months after initiation of anti-TNF therapy.

This News Feature explores the current opinions of leading gastroenterologists on the early use of anti-TNFs for Crohn’s disease and ulcerative colitis.

This News Feature explores the changing landscape of inflammatory bowel disease care focusing on personalised approaches and shared decision-making to support therapy selection.

This news feature considers the role of nutrition in IBD, highlighting the latest insights, and importance of dietary choices along with recent guideline recommendations.

Recent data suggest that older patients presented with personalised information about the benefits and harms of colorectal cancer screening were more likely to receive screening orders that aligned with benefit.